A carregar...

Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.

Continuous delivery of factor VIII (FVIII) protein in hemophiliacs by gene therapy will represent a major clinical advance over the current practice of infrequent administration of purified FVIII. Conceptually, retroviral vectors that can permanently insert the FVIII gene into the DNA of the host ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dwarki, V J, Belloni, P, Nijjar, T, Smith, J, Couto, L, Rabier, M, Clift, S, Berns, A, Cohen, L K
Formato: Artigo
Idioma:en
Publicado em: 1995
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC42629/
https://ncbi.nlm.nih.gov/pubmed/7862626
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!